Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial-Reference-Cited by-同舟云学术

Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial

Published:2015-08 Issue:8 Volume:41 Page:1082-1088
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Wang X.,Shen Y.,Zhao Y.,Li Z.,Gou H.,Cao D.,Yang Y.,Qiu M.,Li Q.,Liu J.,Yi C.,Liao Z.,Luo D.,Xu F.,Bi F.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference32 articles.

1. Process of care failures in invasive cervical cancer: systematic review and meta-analysis;Spence;Prev Med,2007

2. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix;Peters;J Clin Oncol,2000

3. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors;Mabuchi;Gynecol Oncol,2009

4. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix;Green;Cochrane Database Syst Rev,2005

5. Paclitaxel has moderate activity in squamous cervix cancer. A gynecologic Oncology Group study;McGuire;J Clin Oncol,1996

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensity-Modulated Radiation Therapy for Uterine Cervical Cancer to Reduce Toxicity and Enhance Efficacy – an Option or a Must?: A Narrative Review;Cancer Research and Treatment;2024-01-15

2. The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy;Radiation Oncology;2022-05-12

3. Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future;International Journal of Gynecologic Cancer;2022-03

4. Structure-activity insights of harmine targeting DNA, ROS inducing cytotoxicity with PARP mediated apoptosis against cervical cancer, anti-biofilm formation and in vivo therapeutic study;Journal of Biomolecular Structure and Dynamics;2021-01-22

5. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline;Practical Radiation Oncology;2020-07